4 Largecap Five-Year Return 50-100 Per Cent Stocks to Watch for Future Multibagger Potential: SBI, Titan, Divi's Labs and Apollo Hospitals

Five-year return 50-100 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. SBI, Titan, Divi's Labs and Apollo Hospitals meet that test, with market caps from Rs 1.22 lakh crore to Rs 8.69 lakh crore and SBI offering the fastest profit growth, 23.72% a year since FY22. Each of these companies has a five-year share price return between 50 and 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a five-year share price return between 50 and 100 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening five-year return 50-100 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Five-Year Return 50-100 Per Cent Stocks and Why Do They Attract Multibagger Interest?

Five-year return 50-100 per cent stocks are shares that gained from half to double their value over five years, a steady record that shows patient shareholders have been rewarded. The four here cover public sector banking, jewellery and watches, pharmaceutical ingredients and hospitals.

A five-year record of steady gains, backed by rising profit, shows that growth has been sustained and not limited to one good run. For five-year return 50-100 per cent stocks, both FY26 and the latest quarter showed growth. A sensible way to study five-year return 50-100 per cent stocks is to look at profit growth, returns and valuation side by side. Below, each of five-year return 50-100 per cent stocks gets its own breakdown of growth, returns and valuation. Treat five-year return 50-100 per cent stocks as a research list, since share prices and rankings change with every earnings season.

Five-Year Return 50-100 Per Cent Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 28 October 2026. SBI has the lowest PE of the group at 9.69, while Titan posts the highest return on equity at 32.31%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
State Bank of India	956.80	8,68,768	9.69	12.05	14.29%	1.48	877.05 to 1,234.70
Titan Company	4,337.90	3,93,523	68.32	46.75	32.31%	25.06	3,506.50 to 5,186.70
Divi's Laboratories	9,558.50	2,50,368	85.60	36.42	15.32%	14.94	5,647.50 to 9,740.00
Apollo Hospitals Enterprise	8,137	1,22,091	56.21	60.75	20.48%	12.88	6,696.50 to 9,070.50

SBI: 23.72% Profit CAGR Since FY22

State Bank of India is the country's largest lender, with a branch network that reaches every part of India. It reported FY26 total income of Rs 7,12,643.53 crore, up 7.43% year on year, and net profit of Rs 85,168.47 crore, up 7.78%. Net profit has compounded at 23.72% a year since FY22, while total income has grown 15.03% a year.

In the June 2026 quarter, total income rose 7.83% to Rs 1,80,061.86 crore and net profit grew 13.65% to Rs 24,579.04 crore. The share price has gained 92.86% over five years. Foreign investors raised their holding from 9.98% in July 2025 to 10.81% in June 2026. The stock trades at a PE of 9.69 against an industry PE of 12.05, below the sector average, with a return on equity of 14.29%. The dividend yield is 1.85%.

Titan: 23.26% Profit CAGR Since FY22

Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.

The stock trades at a PE of 68.32 against an industry PE of 46.75, with a return on equity of 32.31%. In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026.

Divi's Labs: Debt-to-Equity of 0.00

Divi's Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 85.60 against an industry PE of 36.42, with a return on equity of 15.32%.

Apollo Hospitals: Return on Equity of 20.48%

Apollo Hospitals Enterprise runs one of India's largest hospital networks and also operates pharmacies and a digital health platform. It reported FY26 revenue of Rs 25,420.10 crore, up 15.58% year on year, and net profit of Rs 2,002.70 crore, up 33.06%. Net profit has compounded at 16.13% a year since FY22, while revenue has grown 14.59% a year. Operating margin was 15.80% in FY26.

The stock trades at a PE of 56.21 against an industry PE of 60.75, below the sector average, with a return on equity of 20.48%. In the June 2026 quarter, revenue rose 20.57% to Rs 7,092.30 crore and net profit grew 38.41% to Rs 610.40 crore. The share price has gained 83.08% over five years. Domestic institutions raised their holding from 21.12% in September 2025 to 22.07% in September 2026.

Five-Year Return 50-100 Per Cent Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these five-year return 50-100 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Total Income (Rs Cr)	Net Profit (Rs Cr)	Income Growth (YoY)	4-Year Income CAGR	Latest Quarter Income Growth
SBI	7,12,643.53	85,168.47	7.43%	15.03%	7.83%
Titan	88,136	5,073	44.62%	32.00%	29.31%
Divi's Labs	11,067	2,568	13.95%	5.09%	24.32%
Apollo Hospitals	25,420.10	2,002.70	15.58%	14.59%	20.57%

Check the Univest Screener for live data on these five-year return 50-100 per cent stocks

Institutional Holding in SBI, Titan, Divi's Labs and Apollo Hospitals

Institutional holding shows who is backing these five-year return 50-100 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Apollo Hospitals has the deepest institutional backing, with FII and DII together holding 65.25% as of September 2026. Domestic institutions increased their holding over the past year in Titan (from 12.78% to 15.34%) and Apollo Hospitals (from 21.12% to 22.07%).

Stock	Promoter	FII	DII	Public	Quarter
SBI	55.47%	10.81%	26.64%	7.08%	June 2026
Titan	52.90%	15.38%	15.34%	16.38%	June 2026
Divi's Labs	51.88%	20.38%	19.17%	8.58%	September 2026
Apollo Hospitals	28.02%	43.18%	22.07%	6.72%	September 2026

Risks to Weigh in Five-Year Return 50-100 Per Cent Stocks

Being careful with five-year return 50-100 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Divi's Labs trades at a PE of 85.60 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Five-Year Return 50-100 Per Cent Stocks

Picking from five-year return 50-100 per cent stocks comes down to four checks, applied in order.

1. Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
2. Compare each PE with the industry PE (12.05 to 60.75) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track SBI, Titan, Divi's Labs and Apollo Hospitals live prices.

Conclusion

Among five-year return 50-100 per cent stocks, SBI stands out for the fastest profit growth, 23.72% a year since FY22, Titan for the highest return on equity at 32.31%, Divi's Labs for the strongest latest-quarter profit growth at 65.50% and Apollo Hospitals for 15.58% revenue growth in FY26. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing five-year return 50-100 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Five-Year Return 50-100 Per Cent Stocks to Watch

Which are the best five-year return 50-100 per cent stocks to watch for multibagger potential?

Ans. SBI, Titan, Divi's Labs and Apollo Hospitals are the 4 names this list highlights, with market caps of Rs 8,68,768 crore, Rs 3,93,523 crore, Rs 2,50,368 crore and Rs 1,22,091 crore respectively. SBI is notable for the fastest profit growth, 23.72% a year since FY22. Titan stands out for the highest return on equity at 32.31%. Divi's Labs offers the strongest latest-quarter profit growth at 65.50%. Apollo Hospitals brings 15.58% revenue growth in FY26. These are watchlist names for five-year return 50-100 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Titan a good stock for long-term investors?

Ans. Titan has a return on equity of 32.31%, a PE of 68.32 against an industry PE of 46.75 and a market cap of Rs 3,93,523 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in five-year return 50-100 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can SBI become a multibagger from here?

Ans. SBI has already gained 92.86% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in five-year return 50-100 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 23.72% a year since FY22, and FY26 revenue rose 7.43%. At a PE of 9.69 against an industry PE of 12.05, valuation should be checked against that growth before investing.

What is the market cap of SBI, Titan, Divi's Labs and Apollo Hospitals?

Ans. As of 28 October 2026, SBI has a market cap of Rs 8,68,768 crore, Titan has a market cap of Rs 3,93,523 crore, Divi's Labs has a market cap of Rs 2,50,368 crore and Apollo Hospitals has a market cap of Rs 1,22,091 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on five-year return 50-100 per cent stocks.

What are the risks of investing in five-year return 50-100 per cent stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi's Labs trades at a PE of 85.60 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Divi's Labs trading at a PE of 85.60?

Ans. Divi's Labs' PE of 85.60 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in five-year return 50-100 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in SBI, Titan, Divi's Labs and Apollo Hospitals?

Ans. As of the latest reported quarter, FII and DII together hold 37.45% of SBI (10.81% and 26.64%), 30.72% of Titan (15.38% and 15.34%), 39.55% of Divi's Labs (20.38% and 19.17%) and 65.25% of Apollo Hospitals (43.18% and 22.07%). Rising institutional holding is a useful signal in five-year return 50-100 per cent stocks, though it should be read with earnings trends rather than on its own.